Product Description

Recombinant Human Erythropoietin-alpha Fc/Chimera is a biopharmaceutical drug used to treat anemia by stimulating red blood cell production. Belonging to the erythropoietin family, this medication is produced through genetic engineering techniques, combining the erythropoietin-alpha protein with the Fc region of human immunoglobulin G. With a molecular weight of approximately 37 kDa, Recombinant Human Erythropoietin-alpha Fc/Chimera is administered through injection and works by mimicking the natural hormone erythropoietin to promote the formation of red blood cells in the body.

Current Lead Time

7-14 Days

Product Specifications

*For Research Use Only

If your product is within its expiration period, and has not performed according to expectations, fill out the sample return form. Return the unused sample frozen, with the auto generated packing slip to the address on the instructions. You will receive a full refund along with a replacement of the unused portion (inclusive of the failed test). Damages do not cover any additional costs incurred for failed experimentation. 

Check Uniprot Link

Lyophilized Erythropoietin-a although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution EPO-alpha should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.

It is recommended to reconstitute the lyophilized Erythropoietin in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.

Not Available